|
Name |
4-((1S)-1,5-Dihydroxy-1,5-dimethylhexyl)-3-hydroxybenzoic acid
|
Molecular Formula | C15H22O5 | |
IUPAC Name* |
4-[(2S)-2,6-dihydroxy-6-methylheptan-2-yl]-3-hydroxybenzoic acid
|
|
SMILES |
C[C@](CCCC(C)(C)O)(C1=C(C=C(C=C1)C(=O)O)O)O
|
|
InChI |
InChI=1S/C15H22O5/c1-14(2,19)7-4-8-15(3,20)11-6-5-10(13(17)18)9-12(11)16/h5-6,9,16,19-20H,4,7-8H2,1-3H3,(H,17,18)/t15-/m0/s1
|
|
InChIKey |
YCUWMGPYKGLQQF-HNNXBMFYSA-N
|
|
Synonyms |
Hydroxysydonic acid, (S)-; Hydroxysydonic acid, (+)-; (S)-10-Hydroxysydonic acid; 43S25549XL; 4-((1S)-1,5-Dihydroxy-1,5-dimethylhexyl)-3-hydroxybenzoic acid; Benzoic acid, 4-((1S)-1,5-dihydroxy-1,5-dimethylhexyl)-3-hydroxy-; 1675975-90-2; CHEMBL3577365; UNII-43S25549XL; ZINC13482269
|
|
CAS | 1675975-90-2 | |
PubChem CID | 25775008 | |
ChEMBL ID | CHEMBL3577365 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 282.33 | ALogp: | 2.0 |
HBD: | 4 | HBA: | 5 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 98.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 20 | QED Weighted: | 0.643 |
Caco-2 Permeability: | -5.007 | MDCK Permeability: | 0.00001360 |
Pgp-inhibitor: | 0.005 | Pgp-substrate: | 0.01 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.093 |
Blood-Brain-Barrier Penetration (BBB): | 0.077 | Plasma Protein Binding (PPB): | 47.12% |
Volume Distribution (VD): | 0.348 | Fu: | 51.05% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.57 |
CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.055 |
CYP2C9-inhibitor: | 0.048 | CYP2C9-substrate: | 0.146 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.117 |
CYP3A4-inhibitor: | 0.038 | CYP3A4-substrate: | 0.078 |
Clearance (CL): | 6.24 | Half-life (T1/2): | 0.881 |
hERG Blockers: | 0.045 | Human Hepatotoxicity (H-HT): | 0.216 |
Drug-inuced Liver Injury (DILI): | 0.723 | AMES Toxicity: | 0.009 |
Rat Oral Acute Toxicity: | 0.008 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.057 | Carcinogencity: | 0.019 |
Eye Corrosion: | 0.007 | Eye Irritation: | 0.764 |
Respiratory Toxicity: | 0.012 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002383 | 1.000 | D05VIX | 0.333 | ||||
ENC002564 | 0.700 | D0BA6T | 0.319 | ||||
ENC002688 | 0.672 | D0K5CB | 0.311 | ||||
ENC005624 | 0.667 | D02ZJI | 0.311 | ||||
ENC004442 | 0.667 | D0P7JZ | 0.306 | ||||
ENC003401 | 0.645 | D0Y6KO | 0.289 | ||||
ENC003302 | 0.625 | D0C4YC | 0.286 | ||||
ENC003717 | 0.545 | D01WJL | 0.286 | ||||
ENC005626 | 0.493 | D0SS4P | 0.276 | ||||
ENC002474 | 0.471 | D08HVR | 0.271 |